Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serological studies with human papova (wart) virus.

Literature DB >> 4318815

Serological studies with human papova (wart) virus.

Abstract

Methods for demonstrating antibody to wart virus by complement fixation and passive haemagglutination tests are described and compared with the precipitin test of Almeida & Goffe (1965). The results reveal the much greater sensitivity of the passive haemagglutination method, particularly in the detection of the immunoglobulin M class of antibody. Both complement-fixing and precipitating antibody were detected in sera from patients whose warts had undergone a spontaneous resolution.The presence of antibody to wart virus was demonstrated in sera from persons who had had warts up to 10 years previously, and in a few cases from those who thought they had never had warts.The antigenic identity of virus from hand warts and plantar warts of the simple and mosaic types was revealed, and some evidence was obtained for similar identity of the virus from genital warts.

Entities: Species

Mesh：

Substances：

Year: 1970 PMID： 4318815 PMCID： PMC2130829 DOI： 10.1017/s0022172400042388

Source DB: PubMed Journal: J Hyg (Lond) ISSN： 0022-1724

21 in total

1. RUBELLA COMPLEMENT FIXATION TEST.

Authors: J L SEVER; R J HUEBNER; G A CASTELLANO; P S SARMA; A FABIYI; G M SCHIFF; C L CUSUMANO
Journal: Science Date: 1965-04-16 Impact factor: 47.728

2. Electron microscopic particle counts on herpes virus using the phosphotungstate negative staining technique.

Authors: D H WATSON; W C RUSSELL; P WILDY
Journal: Virology Date: 1963-03 Impact factor: 3.616

3. Electron microscope study of human warts; sites of virus production and nature of the inclusion bodies.

Authors: J D ALMEIDA; A F HOWATSON; M G WILLIAMS
Journal: J Invest Dermatol Date: 1962-06 Impact factor: 8.551

4. Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines.

Authors: C A EVANS; L R GORMAN; Y ITO; R S WEISER
Journal: J Natl Cancer Inst Date: 1962-08 Impact factor: 13.506

5. Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors: C M BRADSTREET; C E TAYLOR
Journal: Mon Bull Minist Health Public Health Lab Serv Date: 1962-05

6. Hemagglutination with herpes simplex virus.

Authors: L V SCOTT; F G FELTON; J A BARNEY
Journal: J Immunol Date: 1957-03 Impact factor: 5.422

7. Papova virus group.

Authors: J L MELNICK
Journal: Science Date: 1962-03-30 Impact factor: 47.728

8. Detection of a small virus in a cultivated human Wilms' tumor.

Authors: J W Smith; D Pinkel; S Dabrowski
Journal: Cancer Date: 1969-09 Impact factor: 6.860

9. Weight estimates of rabbit anti-human serum albumin based on antigen-binding and precipitin analyses: specific hemagglutinating activities of 7 S and 19 S components.

Authors: A G Osler; J J Mulligan; E Rodriguez
Journal: J Immunol Date: 1966-02 Impact factor: 5.422

10. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.

Authors: A Wikström; C Eklund; G Von Krogh; P Lidbrink; J Dillner
Journal: J Clin Microbiol Date: 1992-07 Impact factor: 5.948

Serological studies with human papova (wart) virus.

1. RUBELLA COMPLEMENT FIXATION TEST.

2. Electron microscopic particle counts on herpes virus using the phosphotungstate negative staining technique.

3. Electron microscope study of human warts; sites of virus production and nature of the inclusion bodies.

4. Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines.

5. Technique of complementfixation test applicable to the diagnosis of virus diseases.

6. Hemagglutination with herpes simplex virus.

7. Papova virus group.

8. Detection of a small virus in a cultivated human Wilms' tumor.

9. Weight estimates of rabbit anti-human serum albumin based on antigen-binding and precipitin analyses: specific hemagglutinating activities of 7 S and 19 S components.

10. THE STRUCTURE OF ANTIGEN-ANTIBODY COMPLEXES. A STUDY BY ELECTRON MICROSCOPY.

1. Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.

2. Specific immunity to human papilloma virus (HPV) in patients with genital warts.

3. Serological studies in a student population prone to infection with human papilloma virus.

4. Plantar warts.

5. An immunofluorescence study of warts.

6. Randomized trial of transfer factor treatment of human warts.

7. Characterization of a new type of human papillomavirus that causes skin warts.

8. Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV).

9. Reduction of cell mediated immunity in patients with genital warts of long duration.

10. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.